Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinical guide to amlodipine's FDA approval history, current compounding regulations, label requirements, and what prescribers and patients need to know about legally obtaining this calcium channel blocker.
Read clinical reviewA complete timeline of amlodipine's FDA approval, label updates, generic entry, and post-market safety data from 1987 NDA filing through 2026.
Read clinical reviewA complete guide to amlodipine's regulatory history across the FDA, EMA, and major global agencies, including label requirements, black-box warnings, and post-market safety data.
Read clinical reviewA comprehensive review of every FDA label revision for amlodipine besylate from 2020 through 2026, including new safety warnings, updated drug interactions, and post-market surveillance findings.
Read clinical reviewA complete regulatory history of amlodipine (Norvasc), covering FDA approval, patent litigation, generic entry, labeling updates, and ongoing post-market surveillance.
Read clinical reviewA complete, clinician-reviewed guide to amlodipine's FDA approval history, current label, post-market safety record, and next-generation calcium channel blocker pipeline as of 2025.
Read clinical review